Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24909326 | 1.00 | HTR7 (0.36) | HTR7TMEM97 | |
| SCHEMBL24909723 | 0.78 | HTR7 (0.33) | HTR7TMEM97 | |
| SCHEMBL24908837 | 0.78 | HTR7 (0.35) | HTR7TMEM97 | |
| SCHEMBL24908847 | 0.78 | HTR7 (0.35) | HTR7TMEM97 | |
| SCHEMBL23732613 | 0.70 | HTR7 (0.51) | HTR7TMEM97 | |
| SCHEMBL576921 | 0.69 | HTR7 (0.39) | HTR7TMEM97 | |
| SCHEMBL21880880 | 0.68 | HTR7 (0.52) | HTR7TMEM97 | |
| SCHEMBL805435 | 0.68 | SOAT1 (0.33) | — | |
| SCHEMBL23732376 | 0.68 | HTR7 (0.49) | HTR7TMEM97 | |
| SCHEMBL576526 | 0.67 | HTR7 (0.48) | HTR7TMEM97 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025932-A1 | NOVEL FUNCTIONALIZED LACTONES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | PRAEVENTIX, LLC | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025932-A1 | NOVEL FUNCTIONALIZED LACTONES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | HTR7, HTR2C, HTR3A | HTR7 1/4885TMEM97 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.